Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patients

Belinda Jim, Pascale L. Jean-Louis, Andi Qipo, David Garry, Samia Mian, Tulio Matos, Christopher Provenzano, Anjali Acharya

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Urinary podocyte (podocyturia) has been studied as a diagnostic marker for preeclampsia. We sought to validate its use in preeclampsia and in differentiating it from other high risk pregnancy states. We studied an obstetric population at high risk to develop preeclampsia (study group) and uncomplicated pregnancies (control group) by analyzing their urine sediment for podocytes within 24 hours of delivery. Podocytes were identified by immunohistochemistry using the podocyte-specific protein synaptopodin. Of the 56 patients who were enrolled, 29 patients were diagnosed with preeclampsia, 9 patients had hypertensive conditions such as chronic and gestational hypertension, 6 patients had Type I/II and gestational diabetes mellitus, 3 patients were classified as others, and 9 patients exhibited uncomplicated pregnancies. Podocyturia was identified in 11 out of 29 (38%) of patients with preeclampsia/eclampsia, 3 out of 9 (33%) with gestational and chronic hypertension, and 3 out of 6 (50%) with Type I/II and gestational diabetes mellitus. None of the 9 patients (0%) with uncomplicated pregnancies demonstrated podocyturia. The sensitivity and specificity of podocyturia for preeclampsia were found to be 38% and 70%. Our study showed that podocyturia does not appear to be a sensitive nor a specific marker to diagnose preeclampsia.

Original languageEnglish (US)
JournalJournal of Pregnancy
Volume2012
DOIs
StatePublished - 2012

Fingerprint

Pre-Eclampsia
Podocytes
Pregnancy Induced Hypertension
Gestational Diabetes
Type 1 Diabetes Mellitus
Pregnancy
Type 2 Diabetes Mellitus
High-Risk Pregnancy
Obstetrics
Immunohistochemistry
Urine
Sensitivity and Specificity
Control Groups

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patients. / Jim, Belinda; Jean-Louis, Pascale L.; Qipo, Andi; Garry, David; Mian, Samia; Matos, Tulio; Provenzano, Christopher; Acharya, Anjali.

In: Journal of Pregnancy, Vol. 2012, 2012.

Research output: Contribution to journalArticle

Jim, Belinda ; Jean-Louis, Pascale L. ; Qipo, Andi ; Garry, David ; Mian, Samia ; Matos, Tulio ; Provenzano, Christopher ; Acharya, Anjali. / Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patients. In: Journal of Pregnancy. 2012 ; Vol. 2012.
@article{7e46c797335745c18d3c5c755e5f7941,
title = "Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patients",
abstract = "Urinary podocyte (podocyturia) has been studied as a diagnostic marker for preeclampsia. We sought to validate its use in preeclampsia and in differentiating it from other high risk pregnancy states. We studied an obstetric population at high risk to develop preeclampsia (study group) and uncomplicated pregnancies (control group) by analyzing their urine sediment for podocytes within 24 hours of delivery. Podocytes were identified by immunohistochemistry using the podocyte-specific protein synaptopodin. Of the 56 patients who were enrolled, 29 patients were diagnosed with preeclampsia, 9 patients had hypertensive conditions such as chronic and gestational hypertension, 6 patients had Type I/II and gestational diabetes mellitus, 3 patients were classified as others, and 9 patients exhibited uncomplicated pregnancies. Podocyturia was identified in 11 out of 29 (38{\%}) of patients with preeclampsia/eclampsia, 3 out of 9 (33{\%}) with gestational and chronic hypertension, and 3 out of 6 (50{\%}) with Type I/II and gestational diabetes mellitus. None of the 9 patients (0{\%}) with uncomplicated pregnancies demonstrated podocyturia. The sensitivity and specificity of podocyturia for preeclampsia were found to be 38{\%} and 70{\%}. Our study showed that podocyturia does not appear to be a sensitive nor a specific marker to diagnose preeclampsia.",
author = "Belinda Jim and Jean-Louis, {Pascale L.} and Andi Qipo and David Garry and Samia Mian and Tulio Matos and Christopher Provenzano and Anjali Acharya",
year = "2012",
doi = "10.1155/2012/984630",
language = "English (US)",
volume = "2012",
journal = "Journal of Pregnancy",
issn = "2090-2727",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patients

AU - Jim, Belinda

AU - Jean-Louis, Pascale L.

AU - Qipo, Andi

AU - Garry, David

AU - Mian, Samia

AU - Matos, Tulio

AU - Provenzano, Christopher

AU - Acharya, Anjali

PY - 2012

Y1 - 2012

N2 - Urinary podocyte (podocyturia) has been studied as a diagnostic marker for preeclampsia. We sought to validate its use in preeclampsia and in differentiating it from other high risk pregnancy states. We studied an obstetric population at high risk to develop preeclampsia (study group) and uncomplicated pregnancies (control group) by analyzing their urine sediment for podocytes within 24 hours of delivery. Podocytes were identified by immunohistochemistry using the podocyte-specific protein synaptopodin. Of the 56 patients who were enrolled, 29 patients were diagnosed with preeclampsia, 9 patients had hypertensive conditions such as chronic and gestational hypertension, 6 patients had Type I/II and gestational diabetes mellitus, 3 patients were classified as others, and 9 patients exhibited uncomplicated pregnancies. Podocyturia was identified in 11 out of 29 (38%) of patients with preeclampsia/eclampsia, 3 out of 9 (33%) with gestational and chronic hypertension, and 3 out of 6 (50%) with Type I/II and gestational diabetes mellitus. None of the 9 patients (0%) with uncomplicated pregnancies demonstrated podocyturia. The sensitivity and specificity of podocyturia for preeclampsia were found to be 38% and 70%. Our study showed that podocyturia does not appear to be a sensitive nor a specific marker to diagnose preeclampsia.

AB - Urinary podocyte (podocyturia) has been studied as a diagnostic marker for preeclampsia. We sought to validate its use in preeclampsia and in differentiating it from other high risk pregnancy states. We studied an obstetric population at high risk to develop preeclampsia (study group) and uncomplicated pregnancies (control group) by analyzing their urine sediment for podocytes within 24 hours of delivery. Podocytes were identified by immunohistochemistry using the podocyte-specific protein synaptopodin. Of the 56 patients who were enrolled, 29 patients were diagnosed with preeclampsia, 9 patients had hypertensive conditions such as chronic and gestational hypertension, 6 patients had Type I/II and gestational diabetes mellitus, 3 patients were classified as others, and 9 patients exhibited uncomplicated pregnancies. Podocyturia was identified in 11 out of 29 (38%) of patients with preeclampsia/eclampsia, 3 out of 9 (33%) with gestational and chronic hypertension, and 3 out of 6 (50%) with Type I/II and gestational diabetes mellitus. None of the 9 patients (0%) with uncomplicated pregnancies demonstrated podocyturia. The sensitivity and specificity of podocyturia for preeclampsia were found to be 38% and 70%. Our study showed that podocyturia does not appear to be a sensitive nor a specific marker to diagnose preeclampsia.

UR - http://www.scopus.com/inward/record.url?scp=84866179976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866179976&partnerID=8YFLogxK

U2 - 10.1155/2012/984630

DO - 10.1155/2012/984630

M3 - Article

VL - 2012

JO - Journal of Pregnancy

JF - Journal of Pregnancy

SN - 2090-2727

ER -